The Efficacy of Immune-checkpoint Inhibitors in Combination with Definitive Chemoradiotherapy in Non-metastatic Esophageal SCC: A Systematic Review and Meta-analysis
Adding immunotherapy to radiation improved survival in people with inoperable esophageal cancer, though managing side effects remains important.
BACKGROUND: Inoperable esophageal squamous cell carcinoma (ESCC) remains a challenging malignancy. CONCLUSIONS: The addition of ICIs to definitive radiotherapy-based treatment was associated with improved survival and antitumor activity in patients with inoperable ESCC, although toxicity remains clinically relevant.
What the study was
- Study design
- Systematic Review
- Population
- BACKGROUND: Inoperable esophageal squamous cell carcinoma (ESCC) remains a challenging malignancy
- Sample size
- 4800
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Critical reviews in oncology/hematology
Why it surfaced
High-level evidence synthesis; high triage score
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.